The board of the Sydney-based Viral Vector Manufacturing Facility has appointed Stephen Thompson as its inaugural CEO.
First CEO for the Sydney-based Viral Vector Manufacturing Facility
July 1, 2024 Latest NewsBioPharmaLatest Video
New Stories
-
Committee recommends major overhaul of diabetes management and access
July 5, 2024 - - Latest News -
New report reveals strong growth in valuations of local life science companies
July 5, 2024 - - Latest News -
Merck’s record support for the Australian Multiple Sclerosis Community
July 5, 2024 - - Latest News -
CSL's gene therapy becomes the first funded via the UK's 'Innovative Medicines Fund'
July 5, 2024 - - Latest News -
New Zealand pharmacies to administer more childhood vaccinations
July 4, 2024 - - Latest News -
Patients gather in Canberra to call for access ahead of next week's PBAC meeting
July 4, 2024 - - Latest News -
Medicines Australia wants changes made to draft immunisation strategy
July 3, 2024 - - Latest News